Pfizer drug trial victims start to receive compensation

By Admin
People in Nigeria have started to receive long-awaited compensation payments from Pfizer after a botched drug trial. Eleven children died and dozens mo...

People in Nigeria have started to receive long-awaited compensation payments from Pfizer after a botched drug trial.

Eleven children died and dozens more developed disabilities during a 1996 trial of an experimental drug treatment for meningitis.

Four families have received $175,000 in the first batch of payouts after they obtained DNA evidence their children’s deaths were caused from the trial.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

However, the company has been criticised for only compensating four families in the initial round of payouts despite 200 children taking part in the trial.

The money for the compensation has come from a $35 million fund created as part of the settlement between Pfizer and the northern Kano state in Nigeria where the trial took place.

As part of the settlement Pfizer has also agreed to fund health projects in the Kano region.

However, the company is still insistent the deaths were caused by meningitis and not the drugs it was testing.

In a statement the pharmaceutical company said: “This is the first step in a multi-phase review process by which the independent board of trustees that manages the fund will deliver payment to all other qualified claimants.

“We thank them for their commitment and dedication to seeing this process through in the most timely and transparent way possible.”

Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability